Regulation of Inflammatory Genes in Psoriasis

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT03125655
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - 99 Years
Healthy Volunteers
Accepted

Interventions

  • Inflammatory markers — DIAGNOSTIC_TEST

Study Details

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.

Key Dates

Start date
Apr 22, 2014
Status verified
Apr 2026
Primary completion
Apr 10, 2027
Completion
Apr 28, 2028

Study Design

Enrollment
13 participants (estimated)

Primary Outcome Measure

Inflammatory genes [ Time Frame: 1 day ]

Locations (1)

FacilityCityStateZIPSite coordinators
The Kirklin ClinicBirminghamAlabama35294
Wendy Cantrell
[email protected]
205 502 9960

Find similar trials in Birmingham, AL

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
The Kirklin Clinic· Birmingham, AL

Related Studies